G. Klebb et al., INTERLEUKIN-2 IS INDISPENSABLE FOR DEVELOPMENT OF IMMUNOLOGICAL SELF-TOLERANCE, Clinical immunology and immunopathology, 81(3), 1996, pp. 282-286
Interleukin-2-deficient mice (IL-2(-/-)) manifest severe immune system
abnormalities characterized by an uncontrolled activation and prolife
ration of lymphocytes. A systemic autoimmune syndrome results, and hem
olytic anemia leads to early death especially in mice derived from a B
ALB/c genotype. Remarkably, IL-2 treatment prevents both the activatio
n of the immune system and the development of autoimmune disease. More
over, adoptive transfer of lymphocytes from IL-2-treated IL-2(-/-) ani
mals confers protection to IL-2(-/-) mice, suggesting that IL-2 induce
s a postnatal differentiation/maturation of regulatory cells necessary
for self- and non-self-discrimination. (C) 1996 Academic Press, Inc.